151 related articles for article (PubMed ID: 1378139)
1. Efficacy and safety of carvedilol in comparison with nifedipine sustained-release in chronic stable angina.
van der Does R; Eberhardt R; Derr I; Ehmer B
J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S122-7. PubMed ID: 1378139
[TBL] [Abstract][Full Text] [Related]
2. Treatment of chronic stable angina with carvedilol in comparison with nifedipine s.r.
van der Does R; Eberhardt R; Derr I; Ehmer B; Rudorf J; Uberbacher HJ
Eur Heart J; 1991 Jan; 12(1):60-4. PubMed ID: 2009895
[TBL] [Abstract][Full Text] [Related]
3. Comparison of safety and efficacy of carvedilol and metoprolol in stable angina pectoris.
van der Does R; Hauf-Zachariou U; Pfarr E; Holtbrügge W; König S; Griffiths M; Lahiri A
Am J Cardiol; 1999 Mar; 83(5):643-9. PubMed ID: 10080412
[TBL] [Abstract][Full Text] [Related]
4. Carvedilol versus verapamil in chronic stable angina: a multicentre trial.
Hauf-Zachariou U; Blackwood RA; Gunawardena KA; O'Donnell JG; Garnham S; Pfarr E
Eur J Clin Pharmacol; 1997; 52(2):95-100. PubMed ID: 9174677
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the effects of carvedilol and nifedipine in patients with essential hypertension and non-insulin-dependent diabetes mellitus.
Albergati F; Paternó E; Venuti RP; Boeri D; Lombardo I; Semino S; Viviani GL; Adezati L
J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S86-9. PubMed ID: 1378156
[TBL] [Abstract][Full Text] [Related]
6. A comparison of carvedilol with a combination of propranolol and isosorbide dinitrate in the chronic treatment of stable angina.
Nahrendorf W; Rading A; Steinig G; van der Does R; Schlote A
J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S114-6. PubMed ID: 1378136
[TBL] [Abstract][Full Text] [Related]
7. A randomised double-blind crossover study of isosorbide mononitrate and nifedipine retard in chronic stable angina.
Akhras F; Chambers J; Jefferies S; Jackson G
Int J Cardiol; 1989 Aug; 24(2):191-6. PubMed ID: 2504673
[TBL] [Abstract][Full Text] [Related]
8. Anti-Anginal and Metabolic Effects of Carvedilol and Atenolol in Patients with Stable Angina Pectoris: A Prospective, Randomized, Parallel, Open-Label Study.
Oh PC; Kang WC; Moon J; Park YM; Kim S; Kim MG; Lee K; Ahn T; Shin EK
Am J Cardiovasc Drugs; 2016 Jun; 16(3):221-8. PubMed ID: 27021556
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of three different doses of carvedilol for exertional angina. Carvedilol-Angina Study Group.
Weiss R; Ferry D; Pickering E; Smith LK; Dennish G; Krug-Gourley S; Lukas MA
Am J Cardiol; 1998 Oct; 82(8):927-31. PubMed ID: 9794346
[TBL] [Abstract][Full Text] [Related]
10. [Comparison of carvedilol and atenolol efficacy in patients with stable effort angina].
Martsevich SIu; Koniakhina IP; Alimova EV; Kutishenko NP; Lerman OV
Ter Arkh; 2001; 73(1):38-41. PubMed ID: 11234138
[TBL] [Abstract][Full Text] [Related]
11. [Comparative study to assess the efficacy and adverse effects of amlodipine and nifedipine retard in patients with stable exertional angina and hypertension].
Witkowska M; Tracz W; Kubler G; Negrusz-Kawecka M; Hlawaty M; Olszowska M; Salamon P
Przegl Lek; 1997; 54(5):324-8. PubMed ID: 9380807
[TBL] [Abstract][Full Text] [Related]
12. Multiple action compounds in angina pectoris.
Kelly DT; Freedman SB
Z Kardiol; 1989; 78 Suppl 3():16-20. PubMed ID: 2573212
[TBL] [Abstract][Full Text] [Related]
13. Treatment of chronic stable angina with carvedilol: a multiple-action neurohormonal antagonist. A review of controlled clinical trials.
González Maqueda I
J Int Med Res; 1998; 26(3):107-19. PubMed ID: 9718465
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of a new vasodilating beta-blocking agent, carvedilol, in exertional angina using holter monitoring.
Kishida H; Saito T; Fukuma N; Hata N; Suzuki T; Ohtsu F
Jpn Heart J; 1990 Jul; 31(4):449-60. PubMed ID: 1977939
[TBL] [Abstract][Full Text] [Related]
15. [Amlodipine versus nifedipine retard. A randomized double-blind comparative study on long-term efficacy and safety of amlodipine and nifedipine retard in the monotherapy of chronic stable angina pectoris].
Sauerbrey-Wullkopf N; Kupper W
Herz; 2001 Mar; 26(2):149-56. PubMed ID: 11349617
[TBL] [Abstract][Full Text] [Related]
16. Addition of zatebradine, a direct sinus node inhibitor, provides no greater exercise tolerance benefit in patients with angina taking extended-release nifedipine: results of a multicenter, randomized, double-blind, placebo-controlled, parallel-group study. The Zatebradine Study Group.
Frishman WH; Pepine CJ; Weiss RJ; Baiker WM
J Am Coll Cardiol; 1995 Aug; 26(2):305-12. PubMed ID: 7608428
[TBL] [Abstract][Full Text] [Related]
17. Slow release nifedipine plus atenolol in chronic stable angina pectoris.
Challenor VF; Waller DG; Renwick AG; George CF
Br J Clin Pharmacol; 1989 Nov; 28(5):509-16. PubMed ID: 2511911
[TBL] [Abstract][Full Text] [Related]
18. Comparison of carvedilol and atenolol for angina pectoris.
Freedman SB; Jamal SM; Harris PJ; Kelly DT
Am J Cardiol; 1987 Sep; 60(7):499-502. PubMed ID: 2888302
[TBL] [Abstract][Full Text] [Related]
19. Safety of the coadministration of carvedilol and nifedipine sustained-release in the treatment of essential hypertension.
Juttmann JR; de Vries Robles P; Venuti RP
J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S134-7. PubMed ID: 1378141
[TBL] [Abstract][Full Text] [Related]
20. Effects of carvedilol in patients with impaired left ventricular function due to ischaemic heart disease.
Lahiri A; Rodrigues EA; DasGupta P; Jain D; van der Does R; Raftery EB
Z Kardiol; 1989; 78 Suppl 3():21-7. PubMed ID: 2573213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
